Dec. 21, 2005 — Increased communication between brain cells increases levels of amyloid beta, the key ingredient in Alzheimer's brain plaques, scientists at Washington University School of Medicine in St. Louis have found. Read More >

Dec. 21, 2005 — Investigators at Washington University School of Medicine in St. Louis have found that cells making up a non-visual system in the eye are in place and functioning long before the rods and cones that process light into vision. The discovery should help scientists learn more about the eye's non-visual functions such as the synchronization of the body's internal, circadian clock, the pupil's responses to light and light-regulated release of hormones. Read More >

December 2, 2005 — When Washington University School of Medicine students honored faculty at the Distinguished Service Teaching Awards ceremony November 21, Hope Center Director Mark P. Goldberg, M.D. was the class of 2006's pick for "Clinical Lecturer of the Year." Read More >

The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced a grant of approximately $370,000 over three years to Ceregene, Inc., a biotechnology company based in San Diego, that will partially fund the first clinical trials for CERE-120, a breakthrough gene therapy product shown to slow or stop progression of Parkinson's disease in pre-clinical trials. Read More >

Nov. 18, 2005: A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward techniques for diagnosing Alzheimer's disease before its clinical symptoms become apparent. Read More >

Hope Center member Mark Jacquin has been elected fellow of the national scientific society, the American Association for the Advancement of Science (AAAS). Read More >

Hope Center member Alex S. Evers achieves one of medical science's highest honors as he is elected into the National Academcy of Sciences. Read More >

Oct. 20, 2005 — A molecule that has long been an obstacle to cancer chemotherapy and drug treatments for brain disorders may soon become an ally in the fight against Alzheimer's disease, according to researchers at Washington University School of Medicine in St. Louis and the University of Rochester. Read More >

Sept. 21, 2005 — Jeffrey Milbrandt, M.D., Ph.D, professor of pathology and immunology, internal medicine and of neurology, will become the first David Clayson Professor of Neurology on Sept. 22. Read More >

Hope Center research finds a surprising protective action of pomegranate juice Read More >

Summer 2005 — Artist Jesse Vonk, widow of the late St. Louis Symphony Conductor Hans Vonk, has donated a stone and metal sculpture, In Shadow Of The Rock, to the Hope Center in his memory. Mr. Vonk, a beloved figure who took over the St. Louis Symphony from Leonard Slatkin when Mr. Slatkin moved to the National Symphony Orchestra in Washington , D.C., was treated at Washington University Medical Center for the Lou Gehrig's Disease that ultiamtely took his life. Read More >

Hope Center researcher Alison Goate's genetic studies help pinpoint causal pathways that will lead to molecular targets for new drugs Read More >

March 25, 2005 — Philip V. Bayly, Hope Center member and dual appointee to the School of Engineering's departments of Biomedical Engineering and Mechanical Engineering, is the first Lilyan and E. Lisle Hughes Professor in Engineering. Read More >

February 18, 2005 — Washington University School of Medicine will get a $5.5 million bequest Friday from the estate of Hilda Niess of Trenton, Ill., in Clinton County. Read More >

January 10, 2005 — Time is the most important factor when dealing with stroke, the third leading cause of death in the U.S. But before a person can get a loved one crucial medical treatment in time, he or she must know what signs to heed. WUSM physicians and stroke experts Mark Goldberg and Maurizio Corbetta discuss stroke and its symptoms in the following St. Louis Post-Dispatch article. Read More >